A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

The United Health Foundation to Provide $1M to Support Relief Efforts in Ukraine

The United Health Foundation, the philanthropic foundation of UnitedHealth Group (NYSE: UNH), today announced a $1 million donation to support relief efforts in Ukraine.

The United Health Foundation donation includes:

  • $500,000 to Save the Children, the U.S. affiliate of Save the Children International, to support its Ukraine Crisis Relief Fund to provide children and families with immediate aid such as food, water, hygiene kits and psychosocial support.
  • $500,0000 to Direct Relief, a long-standing United Health Foundation partner on disaster response, to provide emergency medical supplies including critical care medicines, oxygen concentrators, antibiotics and other medical equipment to the Ukrainian Ministry of Health.

“We share deep concern for people in Ukraine amid this humanitarian crisis,” said Patricia Lewis, UnitedHealth Group chief sustainability officer. “This donation will help provide immediate support to families in need, and we’re grateful for the work of both Save the Children and Direct Relief.”

Save the Children has worked in Ukraine since 2014 and is working closely with its Ukrainian affiliate and local partners, while Direct Relief is building on the $26 million in support it has provided to Ukraine over the last six months as part of broader medical aid efforts.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy